Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. India: Macro and Demographic Indicators
    3.1 Healthcare Spending
    3.2 Healthcare Infrastructure
    3.3 Huge Population Base
4. Market Dynamics
    4.1 Drivers
          4.1.1 Rising Demand of Preventive Care Diagnostics
          4.1.2 Rising Burden of Chronic Diseases
          4.1.3 Public - Private Partnership Models for Promoting Diagnostic Services
          4.1.4 Increasing Disposable Income
   4.2 Challenges
          4.2.1 Low Adoption of Advanced In-Vitro Diagnostic Technologies
          4.2.2 Lack of Proper Regulatory Framework
   4.3 Opportunities
          4.3.1 Increasing Investment by Foreign Companies
          4.3.2 Rise in Medical Tourism
          4.3.3 Tele-radiology: Prospective Service Facilitator for Remote Areas
          4.3.4 Emerging Tier II and Tier III cities
   4.4 Trends
         4.4.1 Increasing Automation Driving the Indian Diagnostic Services Market
         4.4.2 Inclination of Doctors towards Debt Financing
         4.4.3 Home Care Health Accessibility: Gaining Consumer Acceptance
         4.4.4 E-packages: New Way to Deliver Diagnostic Services
         4.4.5 Gene Based Testing Methods on the Rise

5. Disease Burden
     5.1 Cancer
     5.2 Cardiovascular Diseases
     5.3 Tuberculosis
     5.4 Malaria
     5.5 HIV/AIDS
     5.6 Diabetes Mellitus
     5.7 Dengue

6. Diagnostic Services Market: Current and Future Analysis
     6.1 Pathology Services
           6.1.1 Market Outlook
           6.1.2 Key Segment Analysis
     6.2 Radiology Services
          6.2.1 Market Outlook
          6.2.2 Key Segment Analysis

7. Diagnostic Services Market: Opportunity Assessment
    7.1 Diagnostics Laboratories: Urban and Rural Split
    7.2 Cost Assessment of Tests: Tier I and Tier II
           7.2.1 Pathological Tests
           7.2.2 Radiological Tests
    7.3 PE Investment Landscape

8. Diagnostic Services: Business Models
     8.1 Public Private Partnership (PPP)
            8.1.1 Understanding of Concept: Indian Scenario
            8.1.2 PPP Model in Healthcare and Diagnostic Services
            8.1.3 Key Healthcare and Diagnostics PPP Projects
            8.1.4 Case Study
     8.2 Single Specialty Model (SSM)
          8.2.1 Understanding the Concept: Indian Scenario
          8.2.2 Model’s Key Advantages
          8.2.3 Case Study
     8.3 Hub and Spoke Model
          8.3.1 Understanding of Concept: Indian Scenario
          8.3.2 Model’s Key Advantages
          8.3.3 Case Study

9.  Consumer Behavior Research in Tier I and II
      9.1 Tier I: Spending Aggressively on Diagnostic Tests
      9.2 Physicians’ Referred Labs Given Highest Preference
      9.3 Brand Popularity: Key Determinant for Lab Preference
      9.4 Independent Labs: Popular Among Respondents
      9.5 Private Lab Facilities Dominating Government Owned Centers
      9.6 Medium Scale Labs: Current Choice of the Respondents

 10.Regulatory Environment: Accreditation and Quality Assurance
       10.1 Requirements for the Shop and Establishment Act
       10.2 NABL Accreditation Mandates
       10.3 NABL Accreditation Procedure
       10.4 Plausible Impact of the Clinical Establishments Act, 2010

11  .Competitive Landscape (Business Overview, and Strength-Weakness Analysis)
       11.1 Super Religare Laboratories
       11.2 Dr. Lal PathLabs
       11.3 Metropolis Healthcare Limited
       11.4 Thyrocare Technologies Limited
       11.5 Quest Diagnostics India Private Limited,
       11.6 PathCare Labs Pvt. Ltd.
       11.7 Oncquest Laboratories Ltd.